Lead optimization and biological evaluation of diazenylbenzenesulfonamides inhibitors against glyoxalase-I enzyme as potential anticancer agents. 2022

Buthina A Al-Oudat, and Nizar A Al-Shar'i, and Qosay A Al-Balas, and Suaad A Audat, and Mohammad A Y Alqudah, and Ali H Hamzah, and Ramez W Hallak, and Mel Bedi, and Amanda Bryant-Friedrich
Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, Jordan University of Science and Technology, P.O. Box 3030, Irbid 22110, Jordan. Electronic address: baoudat@just.edu.jo.

In a previous report, we described the discovery of (E)-5-((8-hydroxyquinolin-5-yl)diazenyl)-2-methylbenzenesulfonamide as a potent inhibitor of GLO-I enzyme with IC50 of 1.28 ± 0.12 μM. Herein, lead optimization of this compound was achieved through targeting the central zinc atom and hydrophilic amino acid residues in the active site of the enzyme. Among the synthesized compounds, compound TS010 showed the most potent inhibitory activity with IC50 of 0.57 ± 0.04 μM. Compound TS013 also showed comparable activity to that of the lead compound with IC50 of 1.14 ± 0.03 μM. Molecular docking studies disclosed the binding mode of the compounds inside the active side of GLO-I enzyme.

UI MeSH Term Description Entries
D007791 Lactoylglutathione Lyase An enzyme that catalyzes the interconversion of methylglyoxal and lactate, with glutathione serving as a coenzyme. EC 4.4.1.5. Glyoxalase I,Lactoyl Glutathione Lyase,Methylglyoxalase,Glutathione Lyase, Lactoyl,Lyase, Lactoyl Glutathione,Lyase, Lactoylglutathione
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking

Related Publications

Buthina A Al-Oudat, and Nizar A Al-Shar'i, and Qosay A Al-Balas, and Suaad A Audat, and Mohammad A Y Alqudah, and Ali H Hamzah, and Ramez W Hallak, and Mel Bedi, and Amanda Bryant-Friedrich
June 1969, Biochemical and biophysical research communications,
Buthina A Al-Oudat, and Nizar A Al-Shar'i, and Qosay A Al-Balas, and Suaad A Audat, and Mohammad A Y Alqudah, and Ali H Hamzah, and Ramez W Hallak, and Mel Bedi, and Amanda Bryant-Friedrich
March 2015, Journal of medicinal chemistry,
Buthina A Al-Oudat, and Nizar A Al-Shar'i, and Qosay A Al-Balas, and Suaad A Audat, and Mohammad A Y Alqudah, and Ali H Hamzah, and Ramez W Hallak, and Mel Bedi, and Amanda Bryant-Friedrich
January 2018, Anti-cancer agents in medicinal chemistry,
Buthina A Al-Oudat, and Nizar A Al-Shar'i, and Qosay A Al-Balas, and Suaad A Audat, and Mohammad A Y Alqudah, and Ali H Hamzah, and Ramez W Hallak, and Mel Bedi, and Amanda Bryant-Friedrich
May 2023, European journal of medicinal chemistry,
Buthina A Al-Oudat, and Nizar A Al-Shar'i, and Qosay A Al-Balas, and Suaad A Audat, and Mohammad A Y Alqudah, and Ali H Hamzah, and Ramez W Hallak, and Mel Bedi, and Amanda Bryant-Friedrich
January 2021, Turkish journal of chemistry,
Buthina A Al-Oudat, and Nizar A Al-Shar'i, and Qosay A Al-Balas, and Suaad A Audat, and Mohammad A Y Alqudah, and Ali H Hamzah, and Ramez W Hallak, and Mel Bedi, and Amanda Bryant-Friedrich
April 1984, Journal of pharmaceutical sciences,
Buthina A Al-Oudat, and Nizar A Al-Shar'i, and Qosay A Al-Balas, and Suaad A Audat, and Mohammad A Y Alqudah, and Ali H Hamzah, and Ramez W Hallak, and Mel Bedi, and Amanda Bryant-Friedrich
November 2019, Pharmaceuticals (Basel, Switzerland),
Buthina A Al-Oudat, and Nizar A Al-Shar'i, and Qosay A Al-Balas, and Suaad A Audat, and Mohammad A Y Alqudah, and Ali H Hamzah, and Ramez W Hallak, and Mel Bedi, and Amanda Bryant-Friedrich
May 2023, Molecules (Basel, Switzerland),
Buthina A Al-Oudat, and Nizar A Al-Shar'i, and Qosay A Al-Balas, and Suaad A Audat, and Mohammad A Y Alqudah, and Ali H Hamzah, and Ramez W Hallak, and Mel Bedi, and Amanda Bryant-Friedrich
September 2011, Journal of medicinal chemistry,
Buthina A Al-Oudat, and Nizar A Al-Shar'i, and Qosay A Al-Balas, and Suaad A Audat, and Mohammad A Y Alqudah, and Ali H Hamzah, and Ramez W Hallak, and Mel Bedi, and Amanda Bryant-Friedrich
December 2014, Bioorganic chemistry,
Copied contents to your clipboard!